ArticleCureus2026
Association of Serum Uric Acid Level as a Risk Factor and Severity Marker With Acute Ischemic Stroke.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Stroke is a major global health burden and a leading cause of mortality. Serum uric acid (SUA) exhibits a dual biological role, acting as an antioxidant at physiological levels while contributing to oxidative stress and endothelial dysfunction when elevated. The association between SUA levels and stroke severity remains controversial. The study aimed to evaluate the association between serum UA levels and acute ischemic stroke and to assess its relationship with functional disability as measured by the Modified Rankin Scale (mRS). Materials and methods This observational cross-sectional study was conducted from June 2024 to December 2025. A total of 63 adult patients with radiologically confirmed acute ischemic stroke presenting within 48 hours of symptom onset were included. SUA levels were measured using the uricase method. Stroke severity was assessed using the mRS at admission. Data were analyzed using SPSS version 26. Comparison across mRS categories was performed using one-way analysis of variance (ANOVA), and correlation was assessed using Spearman's rank correlation coefficient. Results The mean age of participants was 59.4±14.5 years, with male predominance (40; 63.5%). Hypertension (23; 36.5%) and diabetes mellitus (16; 25.4%) were the most common comorbidities. The mean SUA level was 8.0±1.5 mg/dL. Most patients had moderate disability, with 40 patients (63.5%) having an mRS score of 3 and 22 (34.9%) an mRS score of 4. Mean SUA levels increased progressively with stroke severity (p<0.0001). A strong correlation was observed between SUA levels and mRS scores (ρ=0.89, p<0.001). Conclusion Elevated SUA levels are associated with greater functional disability in patients with acute ischemic stroke at presentation. These findings indicate an associative relationship between SUA levels and stroke-related disability rather than a causal or independent prognostic role. Larger prospective studies are required to further clarify the clinical significance of this association.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.